Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT00002647
Phase
PHASE1
Status
Unknown

Conditions

  • Brain and Central Nervous System Tumors
  • Metastatic Cancer

Eligibility Criteria

Sex
ALL
Age
3 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and may be an effective treatment for refractory brain tumors. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy using porfimer sodium in treating patients with refractory brain tumors, including astrocytoma, ependymoma, and medulloblastoma.

Key Dates

Start date
May 31, 1994
Status verified
Jun 2009

Study Design

Enrollment
24 participants (estimated)
Primary purpose
TREATMENT

Locations (2)

FacilityCityStateZIPSite coordinators
Medical College of Wisconsin Cancer CenterMilwaukeeWisconsin53226
Clinical Trials Office - Medical College of Wisconsin Cancer C
414-805-4380
Midwest Children's Cancer Center at Children's Hospital of WisconsinMilwaukeeWisconsin53226
Bruce A. Kaufman, MD
414-266-2000

Find similar trials in Milwaukee, WI

By research site
Medical College of Wisconsin Cancer Center· Milwaukee, WIMidwest Children's Cancer Center at Children's Hospital of Wisconsin· Milwaukee, WI

Related Studies